PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-8.57%
Cash & equivalents declining -8.57% while Healthcare shows -3.49% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.
No Data
No Data available this quarter, please select a different quarter.
-8.57%
Cash + STI yoy growth ≥ 1.5x the Healthcare median of -4.92%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.59%
Exceeding 1.5x Healthcare median of 0.00%. Jim Chanos might suspect questionable capitalization or one-time items inflating current assets.
-8.67%
Current assets growth ≥ 1.5x the Healthcare median of -2.43%. Joel Greenblatt sees a potential liquidity edge if well allocated.
-8.20%
PP&E growth ≥ 1.5x the Healthcare median of -1.95%. Joel Greenblatt sees aggressive expansion. Check if revenue growth supports it.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.26%
Above 1.5x Healthcare median of 0.00%. Jim Chanos sees a red flag for intangible or questionable expansions in the balance sheet.
-7.12%
≥ 1.5x the Healthcare median of -0.81%. Joel Greenblatt sees more aggressive long-term asset growth than peers, but it must be value-accretive.
No Data
No Data available this quarter, please select a different quarter.
-8.62%
≥ 1.5x the Healthcare median of -1.48%. Joel Greenblatt sees more aggressive asset expansion than peers, but must confirm returns are adequate.
-100.00%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
-100.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1405.81%
Above 1.5x Healthcare median of 2.31%. Jim Chanos suspects a potential short-term burden spike.
-20.28%
Below half Healthcare median of 1.73%. Joel Greenblatt sees more conservative short-term leverage than peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.40%
Below half Healthcare median of -1.04%. Joel Greenblatt sees more conservative long-term liability expansion vs. peers.
No Data
No Data available this quarter, please select a different quarter.
-4.61%
Below half Healthcare median of 0.02%. Joel Greenblatt sees a much lower liability expansion vs. peers.
No Data
No Data available this quarter, please select a different quarter.
-3.23%
≥ 1.5x Healthcare median of -1.98%. Joel Greenblatt sees stronger retained profit growth vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.84%
≥ 1.5x Healthcare median of -1.46%. Joel Greenblatt sees stronger equity growth vs. peers.
-8.62%
≥ 1.5x Healthcare median of -1.49%. Joel Greenblatt sees more aggressive expansions than peers.
-100.00%
Below half Healthcare median of 0.00%. Jim Chanos sees potential underinvestment or forced liquidation vs. peers.
-7.46%
Above 1.5x Healthcare median of -1.69%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.
8.60%
Above 1.5x Healthcare median 1.18%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.